GenBank®/EMBL Accession Number
pHTN HaloTag® CMV-neo Accession Number JF920304; pHTN HaloTag® CMV-neo Vector sequence text file.
pFN28A HaloTag® CMV-neo Accession Number JN129497; pFN28A HaloTag® CMV-neo Vector sequence text file.
pFN28K HaloTag® CMV-neo Accession Number JN129498; pFN28K HaloTag® CMV-neo Vector sequence text file.
pFN21A HaloTag® CMV Accession Number EU621374; pFN21A HaloTag® CMV Vector sequence text file.
pFN21K HaloTag® CMV Accession Number EU621375; pFN21K HaloTag® CMV Vector sequence text file.
pFN22A HaloTag® CMVd1 Accession Number EU621376; pFN22A HaloTag® CMVd1 Vector sequence text file.
pFN22K HaloTag® CMVd1 Accession Number EU621377; pFN22K HaloTag® CMVd1 Vector sequence text file.
pFN23A HaloTag® CMVd2 Accession Number EU621378; pFN23A HaloTag® CMVd2 Vector sequence text file.
pFN23K HaloTag® CMVd2 Accession Number EU621379; pFN23K HaloTag® CMVd2 Vector sequence text file.
pFN24A HaloTag® CMVd3 Accession Number EU621380; pFN24A HaloTag® CMVd3 Vector sequence text file.
pFN24K HaloTag® CMVd3 Accession Number EU621381; pFN24K HaloTag® CMVd3 Vector sequence text file.
Store vectors at –20°C.
For product intended use please see Patents & Disclaimers tab.
G7721, G8441, G8451, G2821, G2831, G2841, G2851, G2861, G2871, G2881, G2981, G6050, G3780 For Research Use Only. Not for Use in Diagnostic Procedures.
Patents - Disclaimers
G7721, G8441, G8451, G2821, G2831, G2841, G2851, G2861, G2871, G2881, G2981, G6050, G3780 BY USE OF THIS PRODUCT, RESEARCHER AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE STATEMENT. If the researcher is not willing to accept the conditions of this limited use statement, and the product is unused, Promega will accept return of the unused product and provide the researcher with a full refund. Researchers may use this product for research use only, no commercial use is allowed. Researchers shall have no right to modify or otherwise create variations of the nucleotide sequence of the HaloTag® gene. Researchers may however clone heterologous DNA sequences at either or both ends of said HaloTag® gene so as to create fused gene sequences provided that the coding sequence of the resulting HaloTag® gene has no more than four (4) deoxynucleotides missing at the affected terminus when compared to the intact HaloTag® gene sequence. In addition, researchers must do one of the following in conjunction with use of the product: (1) use Promega HaloTag® ligands, which can be modified or linked to Promega or customer-supplied moieties, or (2) contact Promega to obtain a license if Promega HaloTag® ligands are not to be used. Researchers may transfer derivatives to others for research use provided that at the time of transfer a copy of this label license is given to the recipients and recipients agree to be bound by the terms of this label license. With respect to any uses outside this label license, including any diagnostic, therapeutic or prophylactic uses, please contact Promega for supply and licensing information. PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING FOR MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE WITH REGARDS TO THE PRODUCT. The terms of this agreement shall be governed under the laws of the State of Wisconsin, USA.
G7721, G8441, G8451, G2821, G2831, G2841, G2851, G2861, G2871, G2881, G2981, G6050, G3780 U.S. Pat. Nos. 7,425,436, 7,935,803, 8,466,269, 8,742,086, 8,420,367 and 8,748,148 and other patents and patents pending.
G8441, G8451, G2821, G2831, G2841, G2851, G2861, G2871, G2881, G2981, G6050, G3780 U.S. Pat. Nos. 8,293,503 and 8,367,403, European Pat. No. 1685247 and other patents and patents pending.
G6050, G3780 Patent Pending.
G8441, G8451, G2821, G2831, G2841, G2851, G2861, G2871, G2881, G2981, G6050, G3780 For research use only. Persons wishing to use this product or its derivatives in other fields of use, including without limitation, commercial sale, diagnostics or therapeutics, should contact Promega Corporation for licensing information.
G6050 Licensed under U.S. Pat. No. 5,945,288.